AN2 Therapeutics, Inc.
USD5.02
-0.01 (-0.20%)
CEO
Eric E. Easom
IPO Date
2022-03-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.01
Prev. Close
$5.03
Day Low
$4.92
Day High
$5.10
52W Low
$1.00
52W High
$6.91
Market Cap
$0.14B
Volume
0.02M
| -0.8 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -51.9% | -46.7% | 0.00 | 7.87 | -7.5 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -42.9% | -39.9% | 0.00 | 13.72 | -3.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -34.8% | -33.0% | 0.00 | 17.70 | -13.4 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -494.5% | -321.3% | 0.00 | 2.90 | -21.2 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -702.5% | -593.2% | 0.15 | 35.85 | -8.5 |
| -1.0 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -15.5% | -13.9% | 0.00 | 28.76 | -1.0 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -9.4% | -8.5% | 0.00 | 31.96 | -1.2 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -14.5% | -13.1% | 0.00 | 8.68 | -1.0 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -9.2% | -8.2% | 0.00 | 8.43 | -1.4 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -14.5% | -13.0% | 0.00 | 9.75 | -0.6 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -14.7% | -13.3% | 0.00 | 10.61 | -1.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -15.0% | -13.7% | 0.00 | 10.91 | -1.7 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -13.6% | -12.2% | 0.00 | 7.87 | -9.0 |